Innoviva (INVA) EBITDA (2010 - 2026)

Innoviva has reported EBITDA for 17 years, with the latest figure at $38.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 7.9% year-over-year to $38.2 million; the trailing twelve-month figure through Mar 2026 stood at $107.7 million (down 16.42% YoY), and the FY2025 full-year result was $163.7 million, down 1.87% from the prior year.
• EBITDA for Q1 2026 stood at $38.2 million, up from -$13.8 million in the prior quarter.
• The five-year high for EBITDA was $86.0 million in Q3 2023, with the low at -$13.8 million in Q4 2025.
• Historically, EBITDA has averaged $15.1 million across 5 years, with a median of -$6.6 million in 2023.
• Annual changes were most pronounced in 2022 — EBITDA slumped 109.55% — and 2023, when it jumped 1718940.0%.
• Innoviva's EBITDA stood at -$10.3 million in 2022, then jumped by 36.31% to -$6.6 million in 2023, then sank by 60.22% to -$10.5 million in 2024, then plunged by 31.16% to -$13.8 million in 2025, then jumped by 376.02% to $38.2 million in 2026.
• The last three EBITDA figures came in at $38.2 million (Q1 2026), -$13.8 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.